XJZY(SZ:002332) Xin Lang Cai Jing·2025-09-10 03:05Group 1 - The core point of the news is that Xianju Pharmaceutical's stock price has dropped by 5.04%, currently trading at 10.92 CNY per share, with a total market capitalization of 10.802 billion CNY [1] - Xianju Pharmaceutical, established on June 26, 2000, and listed on January 12, 2010, specializes in the research, production, and sales of steroid raw materials and formulations [1] - The company's main business revenue composition includes corticosteroids (63.39%), gynecological and family planning medications (20.69%), other medications (9.21%), and anesthetics and muscle relaxants (6.71%) [1] Group 2 - Among the top ten circulating shareholders of Xianju Pharmaceutical, a fund under Southern Fund has increased its holdings in the Southern CSI 1000 ETF (512100) by 1.4094 million shares in the second quarter, now holding 7.3351 million shares, which accounts for 0.75% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 26.81% [2] - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 295 days, with the fund's total asset scale at 94.976 billion CNY [3]